P X BIPHASIC ANAPHYLAXIS

 P

Deep Dive: Characteristics of Uniphasic & Biphasic Anaphylaxis in Infants and Toddlers

Based on the study by Rueter et al. (2026), recognizing and managing anaphylaxis in children under 2 years of age presents unique diagnostic challenges compared to older cohorts. Below is a structured analysis of the study's primary findings, clinical signs, biphasic predictors, and post-stabilization observation recommendations.

1. Key Epidemiological & Demographic Findings

• Cohort Size: 243 confirmed infant and toddler cases (aged 0–2 years) out of 1,603 total pediatric anaphylaxis presentations over a 10-year period (2003–2007 and 2013–2017).
  
  
• Demographics: Male predominance (64.2%); over 58% of cases were under 12 months of age.
  
  
• Primary Triggers: Food was the trigger in 93.0% of cases.
  
  
  • Hen’s Egg was the single most common allergen (32.7%), followed by Dairy (20.7%) and Peanuts (18.5%).
    
    
  • Novel food triggers (e.g., coconut, sesame, soy) emerged strictly in the 2013–2017 cohort.
    
    
• Atopic Co-morbidities: 61.5% of cases had a prior diagnosis of eczema, food allergy, or recurrent wheezing.
  
  

2. Clinical Symptom Phenotypes (0–2 Years)

Infants and young toddlers frequently present with non-specific behavioral or cardiovascular signs rather than classical adult patterns.

Organ System	Frequency (%)	Clinical Manifestations & Age-Specific Features
Mucocutaneous	95.8%	Urticaria (85.8%), Angioedema (67.8%), Flushing (21.8%)
Respiratory	81.6%	Wheezing/Persistent Cough (57.7%), Shortness of Breath (32.5%), Stridor (14.5%)
Gastrointestinal	43.1%	Vomiting (42.3%), Diarrhea (5.7%)
Cardiovascular	33.9%	Pallor / Hypotonia ("Floppiness") (33.5%), Hypotension (2.6%)
Neurological	18.8%	Persistent Crying (13.8%), Irritability / Clinginess (7.5%)

Clinical Insight: Hypotension is a late, rare sign (2.6%) due to robust compensatory tachycardia in infants. Central end-organ hypoperfusion presents primarily as pallor, hypotonia, and somnolence. Neurological signs like persistent, unsoothable crying reflect age-specific manifestations of systemic shock.

3. Predictors of Biphasic Anaphylaxis

Biphasic reactions—delayed recurrences without re-exposure—occurred in 4.6% (11/239) of infants/toddlers. All biphasic reactions were food-induced and occurred within 70 to 330 minutes after initial symptom resolution.

Uniphasic vs. Biphasic Comparison

Parameter	Uniphasic (n=228)	Biphasic (n=11)	Statistical Significance (p-value)
Median Age	10.0 months	7.0 months	$p = 0.048$
Systolic BP (mmHg)	102 (median)	80 (median)	$p = 0.011$
Pallor / Hypotonia	32.0%	63.6%	$p = 0.046$
Severe Grade (Muraro)	8.3%	36.4%	$p = 0.014$
IV Fluid Resuscitation	3.1%	45.5%	$p < 0.001$
$\ge 1$ Adrenaline Dose	59.9%	90.9%	$p = 0.050$
Steroid Administration	27.2%	63.6%	$p = 0.015$

Key Biphasic Risk Factors

1. Younger Age: Infants $\le 7$ months were at higher risk.
   
   
2. Cardiovascular Compromise: Significant lower systolic blood pressure, marked pallor, or hypotonia during the primary event.
   
   
3. High Initial Severity: Grade 3 (severe) primary reactions.
   
   
4. Treatment Requirements: Requirement for IV fluid boluses or multiple adrenaline doses during acute stabilization.
   
   

4. Emergency Management & Observation Standards

Treatment Pitfalls Observed

• Undertreatment: Adrenaline was indicated but withheld in 16.5% of cases despite availability.
  
  
• Weight-Based Autoinjector Gaps: 18.9% of infants did not receive an adrenaline autoinjector (AAI) prescription upon discharge due to weighing $<10\text{ kg}$ (below standard AAI minimum weight guidelines at the time of study).
  
  

Recommended Observation Protocols

               [ Infant / Toddler Anaphylaxis Presentation ]
                                     |
                                     v
                  [ Acute Treatment & Stabilization ]
                                     |
               +---------------------+---------------------+
               |                                           |
    [ Standard Risk Profile ]                  [ High-Risk Profile ]
    • Mild/Moderate presentation               • Cardiovascular impairment 
    • Rapid response to 1 dose Adrenaline         (Pallor, hypotonia, lower BP)
    • No IV fluids required                    • Required IV Fluid resuscitation
                                               • Required >= 2 doses Adrenaline
                                               • Severe initial reaction
               |                                           |
               v                                           v
    [ Safe for Discharge at 4h ]               [ Extended Monitoring > 4-6h ]
    (Most biphasic events resolved             (Observation extended due to high 
       within initial 4h window)                  biphasic recurrence risk)

• Standard Observation ($\le 4\text{ hours}$): A mandatory minimum 4-hour observation period captures the vast majority of recurrent presentations in standard, low-risk uniphasic reactions.
  
  
• Extended Observation ($> 4\text{ hours}$): Infants exhibiting cardiovascular signs, requiring IV fluid resuscitation, or presenting with severe primary events must be triaged for prolonged monitoring ($>4\text{–}6\text{ hours}$) or ward admission due to heightened biphasic risk.